Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database

Documenti analoghi

• Assessing taxane-associated adverse events using the FDA adverse event reporting system database
  di: Lao, Dong-Hui, et al.
  Pubblicazione: (2021)
• Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
  di: Chang-Zhu He, et al.
  Pubblicazione: (2025-03-01)
• Reporter’s occupation and source of adverse device event reports contained in the FDA’s MAUDE database
  di: Kavanagh, Kevin T, et al.
  Pubblicazione: (2019)
• Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
  di: Chengzhi Liu, et al.
  Pubblicazione: (2024-12-01)
• Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database
  di: Meng, Long, et al.
  Pubblicazione: (2021)